Clinical Study to Determine Bioequivalence of Oral Tamsulosin Products as 0.4 mg Prolonged-release Tablets in Male Subjects Under Fasted Conditions
NCT07698275
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
34
Enrollment
INDUSTRY
Sponsor class
Conditions
Bioequivalance
Interventions
DRUG:
TAMSULOSIN TEST
DRUG:
OMNIC OCAS REFERENCE
Sponsor
ADIUM